British Thoracic Society Guideline for the investigation and management of malignant pleural mesothelioma I Woolhouse, L Bishop, L Darlison, D De Fonseka, A Edey, J Edwards, ... Thorax 73 (Suppl 1), i1-i30, 2018 | 207 | 2018 |
Investigating unilateral pleural effusions: the role of cytology DT Arnold, D De Fonseka, S Perry, A Morley, JE Harvey, A Medford, ... European Respiratory Journal 52 (5), 2018 | 162 | 2018 |
A novel clinical prediction model for prognosis in malignant pleural mesothelioma using decision tree analysis FJH Brims, TM Meniawy, I Duffus, D de Fonseka, A Segal, J Creaney, ... Journal of Thoracic Oncology 11 (4), 573-582, 2016 | 162 | 2016 |
Nonmalignant pleural effusions: a prospective study of 356 consecutive unselected patients SP Walker, AJ Morley, L Stadon, D De Fonseka, DT Arnold, ARL Medford, ... Chest 151 (5), 1099-1105, 2017 | 112 | 2017 |
Pleural controversies: image guided biopsy vs. thoracoscopy for undiagnosed pleural effusions? G Dixon, D de Fonseka, N Maskell Journal of thoracic disease 7 (6), 1041, 2015 | 95 | 2015 |
Dose De-Escalation of Intrapleural Tissue Plasminogen Activator Therapy for Pleural Infection: The ADAPT Project N Popowicz, O Bintcliffe, D De Fonseka, KG Blyth, NA Smith, F Piccolo, ... Annals of the American Thoracic Society, 2017 | 90* | 2017 |
British thoracic society guideline for pleural disease ME Roberts, NM Rahman, NA Maskell, AC Bibby, KG Blyth, JP Corcoran, ... Thorax 78 (Suppl 3), s1-s42, 2023 | 85 | 2023 |
Prospective validation of the RAPID clinical risk prediction score in adult patients with pleural infection: the PILOT study JP Corcoran, I Psallidas, S Gerry, F Piccolo, CF Koegelenberg, T Saba, ... European Respiratory Journal 56 (5), 2020 | 62 | 2020 |
Prognostication and monitoring of mesothelioma using biomarkers: a systematic review DT Arnold, D De Fonseka, FW Hamilton, NM Rahman, NA Maskell British Journal of Cancer 116 (6), 731-741, 2017 | 48 | 2017 |
BTS guideline for the investigation and management of malignant pleural mesothelioma I Woolhouse, L Bishop, L Darlison, D De Fonseka, A Edey, J Edwards, ... BMJ open respiratory research 5 (1), e000266, 2018 | 44 | 2018 |
Randomised controlled trial to compare the diagnostic yield of positron emission tomography CT (PET-CT) TARGETed pleural biopsy versus CT-guided pleural biopsy in suspected … D de Fonseka, W Underwood, L Stadon, N Rahman, A Edey, C Rogers, ... BMJ Open Respiratory Research 5 (1), e000270, 2018 | 36 | 2018 |
The role of imaging in malignant pleural mesothelioma: an update after the 2018 BTS guidelines S Sinha, AJ Swift, MA Kamil, S Matthews, MJ Bull, P Fisher, D De Fonseka, ... Clinical Radiology 75 (6), 423-432, 2020 | 29 | 2020 |
The prevalence and clinical relevance of nonexpandable lung in malignant pleural mesothelioma. A prospective, single-center cohort study of 229 patients AC Bibby, P Halford, D De Fonseka, AJ Morley, S Smith, NA Maskell Annals of the American Thoracic Society 16 (10), 1273-1279, 2019 | 23 | 2019 |
Local anaesthetic (medical) thoracoscopy services in the UK D de Fonseka, R Bhatnagar, NA Maskell Respiration 96 (6), 560-563, 2018 | 23 | 2018 |
A prospective study to investigate the role of serial serum mesothelin in monitoring mesothelioma D De Fonseka, DT Arnold, L Stadon, A Morley, E Keenan, M Darby, ... BMC cancer 18, 1-7, 2018 | 17 | 2018 |
Exploring the characteristics of patients with mesothelioma who chose active symptom control over chemotherapy as first-line treatment: a prospective, observational, single … AC Bibby, D De Fonseka, AJ Morley, E Keenan, A Addeo, S Smith, ... BMC palliative care 16, 1-7, 2017 | 13 | 2017 |
Empagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial O Abani, A Abbas, F Abbas, J Abbas, K Abbas, M Abbas, S Abbasi, ... The Lancet Diabetes & Endocrinology 11 (12), 905-914, 2023 | 8 | 2023 |
Lymphocyte predominance in blood, pleural fluid, and tumour stroma; a prognostic marker in pleural mesothelioma D De Fonseka, DT Arnold, AJ Morley, M Brett, N Bhatt, A Edey, R Daly, ... BMC Pulmonary Medicine 22 (1), 173, 2022 | 7 | 2022 |
Zoledronic acid in the management of mesothelioma-a feasibility study (Zol-A Trial): study protocol for a randomised controlled trial D de Fonseka, A Morley, L Stadon, E Keenan, S Walker, S Smith, ... Trials 19, 1-8, 2018 | 7 | 2018 |
The role of procalcitonin in the management of pleural infection D De Fonseka, NA Maskell Current Opinion in Pulmonary Medicine 24 (4), 380-383, 2018 | 7 | 2018 |